High Tech Pharm Co., Ltd. (KOSDAQ:106190)

South Korea flag South Korea · Delayed Price · Currency is KRW
14,810
-340 (-2.24%)
At close: Mar 25, 2025, 3:30 PM KST
49.75%
Market Cap 150.46B
Revenue (ttm) 77.51B
Net Income (ttm) 13.71B
Shares Out 10.63M
EPS (ttm) 1,289.00
PE Ratio 10.98
Forward PE n/a
Dividend 100.00 (0.70%)
Ex-Dividend Date Dec 27, 2024
Volume 46,594
Average Volume 45,201
Open 15,200
Previous Close 15,150
Day's Range 14,600 - 15,200
52-Week Range 9,240 - 19,280
Beta 0.82
RSI 35.76
Earnings Date Mar 31, 2025

About High Tech Pharm

High Tech Pharm Co., Ltd. researches and develops, manufactures, and sells injectable carbapenem-based antibiotics worldwide. The company was incorporated in 1998 and is based in Chungju-si, South Korea. [Read more]

Industry Pharmaceutical Preparations
Founded 1998
Employees 65
Stock Exchange KOSDAQ
Ticker Symbol 106190
Full Company Profile

Financial Performance

In 2024, High Tech Pharm's revenue was 77.51 billion, an increase of 0.97% compared to the previous year's 76.77 billion. Earnings were 13.71 billion, an increase of 69.75%.

Financial Statements

News

There is no news available yet.